Developmental Mechanisms of Human Idiopathic Scoliosis
人类特发性脊柱侧凸的发育机制
基本信息
- 批准号:10458399
- 负责人:
- 金额:$ 35.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdherenceAdministratorAdolescentAdvisory CommitteesAnimalsAreaAwardBudgetsCaliforniaCaringChildCommunicationDataData SetDeformityDepositionDevelopmentEnsureEthicsFundingGenomicsGoalsGuidelinesHumanIACUCIdiopathic scoliosisInstitutional Review BoardsKnowledgeManuscriptsMeasuresMedical centerModelingMonitorMusculoskeletal DiseasesOnline SystemsParticipantPathogenesisPediatric HospitalsPersonsPoliciesPreparationProductivityPublicationsQuality ControlRegulationRegulator GenesResearchResearch PersonnelResourcesSan FranciscoSpecific qualifier valueSpinalTexasTimeLineUnited States National Institutes of HealthUniversitiesVertebral columnVisualizationWashingtonWorkZebrafishdata sharingdata submissiongene discoveryhuman subject protectioninnovationlarge scale datamedical schoolsmeetingsmultiple omicsprogramsrelational databasetooltool developmentvirtualweb portal
项目摘要
PROJECT SUMMARY/ABSTRACT (ADMINISTRATIVE CORE)
We have established an innovative Program entitled “Developmental Mechanisms of Human Idiopathic
Scoliosis”. This program combines unbiased gene discovery in humans, modeling and gene discovery in
zebrafish, and genomic analysis of gene regulatory sequences that are defining the underlying causes of
adolescent idiopathic scoliosis (AIS), the most common musculoskeletal disorder in children. Three research
groups are leading these efforts. Project 1 “Human” focuses on AIS gene discovery and is led by Carol Wise,
PD, PI, University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children. Project
2 “Zebrafish” is led by Lila Solnica-Krezel, Washington University School of Medicine St. Louis, and her co-
investigator Dr. Ryan Gray, University of Texas. Project 3 “Genomics” is led by Nadav Ahituv, University of
California San Francisco. The Administrative Core will aid activities of the Program, which is already a working
collaborative, and will be ultimately responsible for its execution and productivity. The Program Director Dr. Wise,
the Core Administrator, Ms. Liza Nowlin, and web portal administrator Dr. Kidane will oversee the administration
of the Program. The Core will facilitate organization, communication, data flow, compliance, and productivity
between the research groups. Specific responsibilities of the Core will be to ensure effective and frequent
communication between component groups of the project by hosting regular meetings either virtually or in
person. These will include regular meetings with the Advisory Committee. Primary purposes of the meetings will be
to rigorously interpret results ensuring quality control, identify progress toward specified goals, and to interact with the
Advisory Committee. The Core will be responsible for confirming that requisite resources are available for each Project,
defining timelines for achieving specified goals, monitoring progress toward those goals, and helping to guide any
necessary programmatic changes. A major goal of our collaborative is to generate knowledge, tools, and resources that
will spur the field of spine deformity research forward. The Administrative Core will also oversee deposition of multi-omics
Programmatic data into SpineSource, a new tool that was developed in the prior award cycle to facilitate and centralize
communication and data sharing. We expect that SpineSource will become an important resource for not only our team
but other researchers and stakeholders in the area of spine and spinal deformity. Otherwise the Administrative Core
will be responsible for regularly monitoring budgets and ensuring that funding is disbursed appropriately, and for
compliance with ethical guidelines, with institutional and federal requirements (e.g. institutional review boards,
institutional animal care and use committees), and with data-sharing policies. Finally, the Core will facilitate the
preparation and submission of manuscripts, ensuring fairness and consistency with NIH public access policies.
In these ways the Core will promote synergistic interaction within the Program and hasten the goal to decipher
the pathogenesis of AIS.
项目概要/摘要(管理核心)
我们已经建立了一个创新的项目,题为“人类特发性
脊柱侧凸”。该计划结合了人类无偏见的基因发现,建模和基因发现,
斑马鱼,以及基因调控序列的基因组分析,这些基因调控序列定义了
青少年特发性脊柱侧凸(AIS)是儿童中最常见的肌肉骨骼疾病。三个研究
这些团体正在领导这些努力。项目1“人类”专注于AIS基因发现,由Carol Wise领导,
PD,PI,德克萨斯大学西南医学中心和德克萨斯苏格兰儿童医院。项目
2“斑马鱼”是由华盛顿大学圣路易斯医学院的莱拉·索尔尼卡-克雷泽尔和她的合作者领导的,
调查员瑞恩·格雷博士德克萨斯大学项目3“基因组学”由纳米比亚大学Nadav Ahituv领导。
加州旧金山弗朗西斯科。行政核心将协助该方案的活动,该方案已经是一个工作方案,
协作,并将最终负责其执行和生产力。项目主任怀斯博士,
核心管理员Liza Nowlin女士和门户网站管理员Kidane博士将监督管理工作
该计划。核心将促进组织、通信、数据流、合规性和生产力
在研究小组之间。核心的具体责任是确保有效和经常地
项目各组成小组之间的沟通,以虚拟方式或在线方式定期举行会议
人.这将包括与咨询委员会定期举行会议。会议的主要目的是
严格解释结果,确保质量控制,确定实现指定目标的进展,并与
咨询委员会。核心委员会将负责确认每个项目都有必要的资源,
确定实现特定目标的时间表,监控实现这些目标的进展,并帮助指导任何
必要的方案修改。我们合作的一个主要目标是产生知识、工具和资源,
将推动脊柱畸形研究领域向前发展。行政核心还将监督多组学的沉积
将编程数据导入SpineSource,这是在上一个授标周期中开发的一种新工具,
通信和数据共享。我们希望SpineSource不仅成为我们团队的重要资源,
以及脊柱和脊柱畸形领域的其他研究人员和利益相关者。否则,行政核心
将负责定期监测预算,确保资金得到适当支付,
遵守道德准则,遵守机构和联邦要求(如机构审查委员会,
机构动物护理和使用委员会),并与数据共享政策。最后,核心将促进
准备和提交手稿,确保与NIH公共获取政策的公平性和一致性。
通过这些方式,核心将促进计划内的协同互动,并加速破译目标。
AIS的发病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAROL A WISE其他文献
CAROL A WISE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAROL A WISE', 18)}}的其他基金
Integrated analyses of genome sequencing in adolescent idiopathic scoliosis families
青少年特发性脊柱侧凸家族基因组测序的综合分析
- 批准号:
10195530 - 财政年份:2021
- 资助金额:
$ 35.7万 - 项目类别:
Integrated analyses of genome sequencing in adolescent idiopathic scoliosis families
青少年特发性脊柱侧凸家族基因组测序的综合分析
- 批准号:
10491053 - 财政年份:2021
- 资助金额:
$ 35.7万 - 项目类别:
Developmental Mechanisms of Human Idiopathic Scoliosis
人类特发性脊柱侧凸的发育机制
- 批准号:
10646373 - 财政年份:2016
- 资助金额:
$ 35.7万 - 项目类别:
Identification of Genetic Susceptibility in Adolescent Idiopathic Scoliosis
青少年特发性脊柱侧凸遗传易感性鉴定
- 批准号:
8067080 - 财政年份:2008
- 资助金额:
$ 35.7万 - 项目类别:
Identification of Genetic Susceptibility in Adolescent Idiopathic Scoliosis
青少年特发性脊柱侧凸遗传易感性鉴定
- 批准号:
7812030 - 财政年份:2008
- 资助金额:
$ 35.7万 - 项目类别:
Identification of Genetic Susceptibility in Adolescent Idiopathic Scoliosis
青少年特发性脊柱侧凸遗传易感性鉴定
- 批准号:
8279117 - 财政年份:2008
- 资助金额:
$ 35.7万 - 项目类别:
Identification of Genetic Susceptibility in Adolescent Idiopathic Scoliosis
青少年特发性脊柱侧凸遗传易感性鉴定
- 批准号:
7465814 - 财政年份:2008
- 资助金额:
$ 35.7万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Fellowship Programs














{{item.name}}会员




